https://www.selleckchem.com/Bcl-2.html
To examine whether anesthesia exposure is associated with neurocognitive decline in pediatric medulloblastoma. Patients were treated at St. Jude Children's Research Hospital and completed ≥2 protocol-directed neurocognitive assessments (n=107)as part of a multisite clinical trial for pediatric medulloblastoma (NCT00085202). Patients received risk-adapted craniospinal photon irradiation, followed by four cycles of high-dose chemotherapy and stem cell rescue. Neurocognitive testing was completed at study baseline (after surgery and 2 weeks of st